TIRZEPATIDE (Mounjaro®)

Clinical Indication

For treating type 2 diabetes

Comments

As per NICE TA924

Date of classification

December 2023

Yellow

Specialist recommendation: Medicines initiated (and stabilised where appropriate) or recommended by a specialist service for prescribing in primary care. Requests should be clearly communicated either through written communication including using approved paperwork if available or verbal means as appropriate .